shutterstock_1396957739_pavel_kapysh
Pavel Kapysh / Shutterstock.com
17 December 2019Big PharmaSaman Javed

Fed Circuit dismisses Hospira appeal, says it must pay Amgen $70m

A subsidiary of Pfizer, Hospira, infringed one of Amgen’s patents and must pay damages of $70 million, the US Court of Appeal for the Federal Circuit has affirmed.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
6 November 2019   Pfizer and Indian drugmaker Sun Pharmaceuticals have agreed to settle patent litigation over a generic version of Pfizer’s leukaemia drug, Bosulif.

More on this story

Americas
6 November 2019   Pfizer and Indian drugmaker Sun Pharmaceuticals have agreed to settle patent litigation over a generic version of Pfizer’s leukaemia drug, Bosulif.

More on this story

Americas
6 November 2019   Pfizer and Indian drugmaker Sun Pharmaceuticals have agreed to settle patent litigation over a generic version of Pfizer’s leukaemia drug, Bosulif.